After the landmark success of (Remdesivir),(Favipiravir) & (Molnupiravir) in our fight against covid-19,Bio-Labs once again proves its solid stance by the launch of FDA approved oral treatment to effectively lower the Viral load of SARS-Cov-2 and other associated symptoms.

Bio-Labs launched the most effective combination of Nirmatrelvir and Ritonavir (Bioxovid) for fight against the Omicron and other variants of COVID-19.

The combination of Nirmatrelvir and Ritonavir is FDA approved for COVID-19 variants.